Celcuity Inc. (CELC) vs Enliven Therapeutics, Inc. (ELVN)
A side-by-side comparison of Celcuity Inc. and Enliven Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELC
Celcuity Inc.
$71.25HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ELVN
Enliven Therapeutics, Inc.
$42.39HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CELC vs ELVN
growth of $100 · dividends reinvested · last 7yCELC +934.0% (+39.6%/yr)ELVN -24.2% (-3.9%/yr)CELC compounded faster over this window
Log scale — wide-divergence pair
CELC ELVN
CELC vs ELVN: by the numbers
- •CELC is the larger company ($3.47B vs $3.03B market cap).
Metrics side by side
Valuation
| Metric | CELC | ELVN |
|---|---|---|
| P/B ratio | N/A | 3.38 |
Profitability
| Metric | CELC | ELVN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -11.83% |
| ROIC | -28.15% | -13.88% |
Growth (annualized)
| Metric | CELC | ELVN |
|---|---|---|
| Total return CAGR (5Y) | 34.40% | 24.57% |
Frequently asked
- How have CELC and ELVN total returns compared?
- Over the past 5 years, CELC delivered 34.40% and ELVN delivered 24.57% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.